Showing results (1241-1250 of 1,351) with videos related to

Sort By:
Pageof 136
Therapeutic Advances in Gastroenterology|September 2, 2025
The CROCO (CROhn's Disease COhort Study) - study design and protocolJoana Revés, Anthony Buisson, Johan Burisch, et al.
The Journal of Pediatrics|April 23, 2011
Procalcitonin is a predictor for high-grade vesicoureteral reflux in children: meta-analysis of individual patient dataSandrine Leroy, Carla Romanello, Annick Galetto-Lacour, et al.
BJU International|September 24, 2013
National prospective study on the use of local haemostatic agents during partial nephrectomyHerve Lang, Pascal Mouracade, Pierre Gimel, et al.
Nature Cell Biology|February 7, 2018
Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomasOlivier Zajac, Joel Raingeaud, Fotine Libanje, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 16, 2021
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020Arnaud Fontanet, Laura Tondeur, Rebecca Grant, et al.
Obesity (Silver Spring, Md.)|September 29, 2021
History of bariatric surgery and COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO studyClaire Blanchard, Tanguy Perennec, Sarra Smati, et al.
World Journal of Urology|November 26, 2013
Is there a volume-outcome relationship for partial nephrectomy?J-P Couapel, K Bensalah, J-C Bernhard, et al.
ACS Central Science|May 27, 2024
A Fast-Binding, Functionally Reversible, COX-2 Radiotracer for CNS PET ImagingMichael S Placzek, Daniel K Wilton, Michel Weïwer, et al.
Lancet (London, England)|August 3, 2024
Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 studyAlwin Krämer, Tilmann Bochtler, Chantal Pauli, et al.
Cell Death & Disease|April 8, 2025
The SIRT1 activator SRT2104 exerts exercise mimetic effects and promotes Duchenne muscular dystrophy recoveryMatteo Giovarelli, Silvia Zecchini, Silvia Rosanna Casati, et al.
Pageof 136